These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 28366835)
1. Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective. Raschi E; Bianchin M; De Ponti R; De Ponti F; Ageno W Pharmacol Res; 2017 Jun; 120():206-218. PubMed ID: 28366835 [TBL] [Abstract][Full Text] [Related]
2. Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? Raschi E; Bianchin M; Fantoni C; Ageno W; De Ponti F; De Ponti R Intern Emerg Med; 2017 Oct; 12(7):923-934. PubMed ID: 28785902 [TBL] [Abstract][Full Text] [Related]
3. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations. van Es N; Büller HR Hematology Am Soc Hematol Educ Program; 2015; 2015():125-31. PubMed ID: 26637711 [TBL] [Abstract][Full Text] [Related]
4. Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. Raschi E; Bianchin M; Ageno W; De Ponti R; De Ponti F Drug Saf; 2016 Dec; 39(12):1175-1187. PubMed ID: 27696300 [TBL] [Abstract][Full Text] [Related]
5. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review. Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174 [TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding. Palareti G Semin Hematol; 2014 Apr; 51(2):102-11. PubMed ID: 24861794 [TBL] [Abstract][Full Text] [Related]
8. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention. Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
10. Recent evidence for direct oral anticoagulants in chronic kidney disease. Ha JT; Badve SV; Jun M Curr Opin Nephrol Hypertens; 2019 May; 28(3):251-261. PubMed ID: 30789840 [TBL] [Abstract][Full Text] [Related]
11. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review. Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis. Ross JA; Miller MM; Rojas Hernandez CM Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of cancer associated thrombosis: Which role for direct oral anticoagulants in 2018?]. Frère C; Farge D J Med Vasc; 2018 Sep; 43(5):293-301. PubMed ID: 30217343 [TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review. Hoolwerf EW; Kraaijpoel N; Büller HR; van Es N Thromb Res; 2018 Oct; 170():102-108. PubMed ID: 30153564 [TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials. Dufrost V; Wahl D; Zuily S Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580 [TBL] [Abstract][Full Text] [Related]
16. Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants. Chan NC; Eikelboom JW; Weitz JI Circ Res; 2016 Apr; 118(9):1409-24. PubMed ID: 27126650 [TBL] [Abstract][Full Text] [Related]
17. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis. Sanchez-Redondo J; Espinosa G; Varillas Delgado D; Cervera R Clin Ther; 2019 Sep; 41(9):1839-1862. PubMed ID: 31405527 [TBL] [Abstract][Full Text] [Related]
18. The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead? Cohen AT; Granziera S; Veronese N; Zoppellaro G Semin Respir Crit Care Med; 2017 Feb; 38(1):29-39. PubMed ID: 28208196 [TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis. Hum J; Shatzel JJ; Jou JH; Deloughery TG Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449 [TBL] [Abstract][Full Text] [Related]
20. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies. Deitelzweig S; Farmer C; Luo X; Vo L; Li X; Hamilton M; Horblyuk R; Ashaye A Curr Med Res Opin; 2017 Sep; 33(9):1583-1594. PubMed ID: 28644048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]